203 related articles for article (PubMed ID: 27151562)
1. Differential effects of endogenous, phyto and synthetic cannabinoids on thrombogenesis and platelet activity.
Grambow E; Strüder D; Klar E; Hinz B; Vollmar B
Biofactors; 2016 Nov; 42(6):581-590. PubMed ID: 27151562
[TBL] [Abstract][Full Text] [Related]
2. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM
J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227
[TBL] [Abstract][Full Text] [Related]
3. Anandamide inhibits transport-related oxygen consumption in the loop of Henle by activating CB1 receptors.
Silva GB; Atchison DK; Juncos LI; García NH
Am J Physiol Renal Physiol; 2013 Feb; 304(4):F376-81. PubMed ID: 23220721
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid-induced changes in respiration of brain mitochondria.
Fišar Z; Singh N; Hroudová J
Toxicol Lett; 2014 Nov; 231(1):62-71. PubMed ID: 25195527
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoids control platelet activation and limit aggregate formation under flow.
De Angelis V; Koekman AC; Weeterings C; Roest M; de Groot PG; Herczenik E; Maas C
PLoS One; 2014; 9(9):e108282. PubMed ID: 25264625
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Aug; 56(2):132-9. PubMed ID: 17574859
[TBL] [Abstract][Full Text] [Related]
7. [Cannabinoid applications in glaucoma].
Pinar-Sueiro S; Rodríguez-Puertas R; Vecino E
Arch Soc Esp Oftalmol; 2011 Jan; 86(1):16-23. PubMed ID: 21414525
[TBL] [Abstract][Full Text] [Related]
8. The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes.
Kracke GR; Stoneking SP; Ball JM; Tilghman BM; Washington CC; Hotaling KA; Johnson JO; Tobias JD
Naunyn Schmiedebergs Arch Pharmacol; 2007 Dec; 376(4):285-93. PubMed ID: 17960365
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of platelet activation induced by endocannabinoids in blood and plasma.
Brantl SA; Khandoga AL; Siess W
Platelets; 2014; 25(3):151-61. PubMed ID: 23789792
[TBL] [Abstract][Full Text] [Related]
10. Effect of cannabinoids on platelet serotonin uptake.
Velenovská M; Fisar Z
Addict Biol; 2007 Jun; 12(2):158-66. PubMed ID: 17508987
[TBL] [Abstract][Full Text] [Related]
11. On the effects of CP 55-940 and other cannabinoid receptor agonists in C6 and U373 cell lines.
Ortega A; Rangel-López E; Hidalgo-Miranda A; Morales A; Ruiz-García E; Meneses-García A; Herrera-Gómez A; Aguilar-Ponce JL; González-Herrera IG; Guevara-Salazar P; Prospero-García O; Del Angel SA
Toxicol In Vitro; 2015 Oct; 29(7):1941-51. PubMed ID: 26255146
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.
Shivachar AC
Biochem Pharmacol; 2007 Jun; 73(12):2004-11. PubMed ID: 17445778
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties.
García-Arencibia M; González S; de Lago E; Ramos JA; Mechoulam R; Fernández-Ruiz J
Brain Res; 2007 Feb; 1134(1):162-70. PubMed ID: 17196181
[TBL] [Abstract][Full Text] [Related]
14. CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations.
Citraro R; Russo E; Ngomba RT; Nicoletti F; Scicchitano F; Whalley BJ; Calignano A; De Sarro G
Epilepsy Res; 2013 Sep; 106(1-2):74-82. PubMed ID: 23860329
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
[TBL] [Abstract][Full Text] [Related]
16. Do cannabinoids exhibit a tyramine-like effect?
Ilayan E; Feliszek M; Malinowska B; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2013 Dec; 386(12):1041-6. PubMed ID: 23900610
[TBL] [Abstract][Full Text] [Related]
17. Anandamide in primary sensory neurons: too much of a good thing?
Sousa-Valente J; Varga A; Ananthan K; Khajuria A; Nagy I
Eur J Neurosci; 2014 Feb; 39(3):409-18. PubMed ID: 24494681
[TBL] [Abstract][Full Text] [Related]
18. Differential stimulatory effects of cannabinoids on VIP release and NO synthase activity in synaptosomal fractions from rat ileum.
Kurjak M; Hamel AM; Allescher HD; Schusdziarra V; Storr M
Neuropeptides; 2008; 42(5-6):623-32. PubMed ID: 18829105
[TBL] [Abstract][Full Text] [Related]
19. Normal aging in rats and pathological aging in human Alzheimer's disease decrease FAAH activity: modulation by cannabinoid agonists.
Pascual AC; Martín-Moreno AM; Giusto NM; de Ceballos ML; Pasquaré SJ
Exp Gerontol; 2014 Dec; 60():92-9. PubMed ID: 25456842
[TBL] [Abstract][Full Text] [Related]
20. New Pyridone-Based Derivatives as Cannabinoid Receptor Type 2 Agonists.
Faúndez-Parraguez M; Alarcón-Miranda C; Cho YH; Pessoa-Mahana H; Gallardo-Garrido C; Chung H; Faúndez M; Pessoa-Mahana D
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
